Skip to content

Optimization strategy of anesthesia for thoracoscopic radical resection of lung cancer: stellate ganglion and serratus anterior plane block combined with general anesthesia

Optimization strategy of anesthesia for thoracoscopic radical resection of lung cancer: stellate ganglion and serratus anterior plane block combined with general anesthesia

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2100041727
Enrollment
Unknown
Registered
2021-01-03
Start date
2021-02-01
Completion date
Unknown
Last updated
2021-03-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Lung cancer requiring surgical resection

Interventions

Group G(control group):There was no intervention
Group SG:Combined with serratus anterior plane block
Group SSG :Combined stellate ganglion and serratus anterior plane block

Sponsors

Xiangya Hospital of Changde
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 75 Years

Inclusion criteria

Inclusion criteria: 1. ASA grade I - II, male or female, aged 43-75 years, weighing 49-77 kg. 2. Preoperative malampati score of difficult airway was grade I - II. 3. Laparoscopic radical resection of lung cancer was performed.

Exclusion criteria

Exclusion criteria: 1. Patients with local anesthetic allergy, glaucoma, hypertension, diabetes, heart and brain disease, asthma or airway hyperresponsiveness, difficulty in intubation during anesthesia, change of operation mode during operation, operation time 70 MIM, and intraoperative blood loss > 400 ml were excluded. 2. Patients with block failure, infection of puncture site, recent radiotherapy and chemotherapy, use of analgesic and sedative drugs, and failure to cooperate were excluded. 3. Patients with postoperative non anesthesia related complications were excluded.

Design outcomes

Primary

MeasureTime frame
Dosage of analgesics;Postoperative analgesia effect;

Secondary

MeasureTime frame
Intraoperative vital signs;Postoperative adverse reactions;Comfort evaluation;Length of stay;

Countries

China

Contacts

Public ContactSun Zhihua

Xiangya Hospital

1036725887@qq.com+86 13548560980

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026